Loading...
Keywords
Last Name
Institution

An Open Label, Prospective, Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Oseltamivir (Tamiflu®) in the Treatment of Children 1 to 12 years of age with Influenza Infection


Collapse Biography 

Collapse Time 
Collapse start date
2010-01-01
Collapse end date
2011-12-31